{
    "nctId": "NCT05213403",
    "briefTitle": "Innovative \"Scoring System\" in Breast Cancer Post Neoadiuvant Chemotherapy",
    "officialTitle": "Innovative \"Scoring System\" in Breast Cancer: a Valid Surgical Choice After Neoadjuvant Chemotherapy",
    "overallStatus": "COMPLETED",
    "conditions": "Early Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 255,
    "primaryOutcomeMeasure": "Development of a new scoring system",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients undergoing neoadjuvant chemotherapy\n* Surgery: Breast conservative surgery; Oncoplastic surgery type II; Conservative mastactomy (nipple sparing - NSM or skin sparing - SSM)\n\nExclusion Criteria:\n\n* lack of initial staging or restaging;\n* previous or synchronous history of systemic malignant neoplasms.\n* history of homo-or contralateral breast cancer.\n* initial evidence of metastatic pathology or development of metastases during noeadjuvant chemotherapy (Stage IV)\n* indication to modified radical mastectomy (MRM) without delayed reconstruction",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}